Canbay A et al. Increasing risk of disease progression and mortality in non-alcoholic fatty liver disease/non-alcoholic statohepatitis patients with advanced liver disease: A German real-world analysis. (Abstract PS-060),Boursier J et al. Increased risk of mortality with liver disease progression in non-alcoholic fatty liver disease/non-alcoholic statohepatitis patients: An analysis of French national hospital care. (Abstract THU-299)
Gebruik van anti-IL-6 in tweede en derde trimester van de zwangerschap
dec 2024 | JIA, RA, Virale infecties